Alerts will be sent to your verified email
Verify EmailWOCKPHARMA
Wockhardt
|
Gland Pharma
|
JB Chem & Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Domestic Sales Growth - YoY
|
10.6 % | n/a | 10.1 % |
R&D as a % of Total Sales
|
4.6 % | 4.9 % | 1.16 % |
Financials
|
|||
5 yr Average ROE
|
-3.81 % | 14.74 % | 19.44 % |
5yr average Equity Multiplier
|
2.26 | 1.13 | 1.5 |
5yr Average Asset Turnover Ratio
|
0.39 | 0.53 | 0.79 |
5yr Avg Net Profit Margin
|
-4.46 % | 24.17 % | 16.41 % |
Price to Book
|
6.63 | 3.04 | 7.88 |
P/E
|
0.0 | 39.84 | 41.0 |
5yr Avg Cash Conversion Cycle
|
-118.47 Days | 72.51 Days | 19.31 Days |
Inventory Days
|
68.12 Days | 117.52 Days | 51.72 Days |
Days Receivable
|
71.63 Days | 78.29 Days | 63.93 Days |
Days Payable
|
260.3 Days | 103.04 Days | 85.63 Days |
5yr Average Interest Coverage Ratio
|
-0.67 | 205.64 | 65.09 |
5yr Avg ROCE
|
-1.45 % | 19.61 % | 23.24 % |
5yr Avg Operating Profit Margin
|
3.11 % | 32.0 % | 23.72 % |
5 yr average Debt to Equity
|
0.71 | 0.01 | 0.08 |
5yr CAGR Net Profit
|
46.24 % | -0.01 % | 15.23 % |
5yr Average Return on Assets
|
-1.84 % | 13.18 % | 13.06 % |
Shareholdings
|
|||
Promoter Holding
|
49.09 % | 51.83 % | 47.84 % |
Share Pledged by Promoters
|
18.24 % | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-18.04 % | -6.17 % | -6.16 % |
Change in Mutual Fund Holding (3 Yrs)
|
7.53 % | 19.94 % | 1.99 % |
Wockhardt
|
Gland Pharma
|
JB Chem & Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|